No Cognitive Benefits Seen for Elderly Who Stop HTN Rx

This article originally appeared here.
Share this content:
No Cognitive Benefits Seen for Elderly Who Stop HTN Rx
No Cognitive Benefits Seen for Elderly Who Stop HTN Rx

TUESDAY, Aug. 25, 2015 (HealthDay News) -- Discontinuing antihypertensive treatment in seniors with mild cognitive deficits does not improve mental functioning, according to research published online Aug. 24 in JAMA Internal Medicine.

Justine Moonen, M.D., of Leiden University Medical Center in the Netherlands, and colleagues included 385 people, aged 75 and older. All had mild cognitive deficits and were taking antihypertensive medications. None had serious cardiovascular disease. Half of the participants were randomly selected to stop their antihypertensive treatment, while the other half continued their medication. Both groups were followed for four months.

By the end of that time, the team saw no improvement in the participants' cognitive functioning, whether they stopped the medications or not. The researchers said there are a number of possible reasons why halting antihypertensive treatment had no effect on brain function, including the fact that none of the participants had serious cardiovascular disease.

According to the researchers, future studies with longer follow-up might help determine if seniors with poor cerebral blood flow could benefit from more relaxed blood pressure targets.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »